![]() |
||||||
TherMatrx® Office Thermo Therapy™ TherMatrx® Office Thermo Therapy™ is an effective treatment for relief of enlarged prostate, also known as benign prostatic hyperplasia (BPH). TherMatrx is the most widely used BPH thermotherapy treatment in the United States because of its:
TherMatrx is not surgery—TherMatrx does not require cutting, heavy sedation or hospitalization, and is not surgery. It has been designed for use in your doctor's office.1 TherMatrx doesn't interfere with the use of medications for erectile dysfunction—Viagra®, Cialis®, and Levitra® are examples of erectile dysfunction medications.
No cutting or incision is needed. Instead, the urologist temporarily inserts a small, flexible catheter into the urethra; the system begins to work by slowly raising the temperature in a very specific area of the prostate. This causes changes in the prostate tissue that results in increased urine flow.
The symptoms associated with your enlarged prostate begin to improve within six weeks as you begin to improve your overall quality of life. For most men, a single treatment is effective for long-term relief. Benefits
A small, flexible catheter is inserted into the urethra, the canal that carries urine from the bladder. After it is placed, the system will begin to work by slowly raising the temperature in a very specific area of the prostate. The TherMatrx® system continuously measures the prostate temperature and ensures you are given the optimal "dose" of heat.
1. Transurethral Microwave Thermotherapy System. TherMatrx TMx-2000. PMA P000043 summary of safety and effectiveness data. Approved June 29, 2001. Available at: www.fda.gov/cdrh/pdf/p000043.html. 2. Tepera C, Albala D, Andriole G, Davis BE, Kabalin JN, Lingeman, Nuzzarello J, Eure GR. Transurethral microwave thermotherapy (TUMT) using the TherMatrx TMX-2000. Improved sexual function exhibited in a randomized, blinded study comparing TUMT with a sham procedure in patients with benign prostatic hyperplasia (BPH). 52nd Annual James C. Kimbrough Urological Seminar Jan 26-21, 2005. Honolulu, Hawaii. 3. Albala D, Andriole G, Davis B, Eure G, Kabalin J, Lingeman J, Nuzzarello. Transurethral microwave thermotherapy (TUMT) using the TherMatrx TMX-2000 for treatement of benign prostatic hyperplasia: 5-year follow-up of multicentre randomised pivotal trial. Eur Urol Apr 2006;5(2 suppl.):234 abstract 846. 8. Albala DM, Turk TM, Fulmer BR, Koleski F, Andriole G, Davis BE, Eure GR, Kabalin JN, Lingeman J, Nuzzarello J, Sundaram C. Periurethral transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia: an interim 1-year safety and efficacy analysis using the thermatrx TMx-2000. Tech Urol. Dec 2000;6(4):288-93. |
||||||